{
  "id": 5667,
  "url": "https://nnemf.org/research/5667-evaluation-of-bcl2-and-its-regulatory-mirs-mir",
  "title": "EVALUATION OF BCL2 AND ITS REGULATORY MIRS, MIR-15-B AND MIR-16 EXPRESSION CHANGES UNDER THE EXPOSURE OF EXTREMELY LOW-FREQUENCY ELECTROMAGNETIC FIELDS ON HUMAN GASTRIC CANCER CELL LINE.",
  "authors": [
    "Sahar Heidari",
    "Soheila Abdi",
    "Shohreh Zare Karizi"
  ],
  "journal": "Radiation protection dosimetry",
  "year": "2021",
  "doi": "10.1093/rpd/ncab163",
  "pmid": "34791478",
  "abstract": "In this research, changes in the expression of B-cell lymphoma 2 (BCL2), miR-15-b and miR-16 in human adenocarcinoma gastric cancer cell line (AGS) following the exposure to magnetic flux densities (MFDs) of 0.2 and 2 mT continuously and discontinuously (1.5 h on/1.5 h off) for 18 h were investigated. Changes in the cell viability were evaluated by the MTT assay. Real-time PCR was used to evaluate the expression changes of BCL2, miR-15-b and miR-16. The results showed that extremely low frequency electromagnetic field (ELF-EMF) could significantly reduce the viability of AGS cells in the continuous MFD of 2 mT. The BCL2 expression was significantly decreased following the exposure to continuous MFDs of 0.2 and 2 mT and discontinuous MFD of 2 mT. The expressions of miR-15-b and miR-16 were significantly increased in continuous and discontinuous MFD of 2 mT. According to the results, weak and moderate extremely low-frequency electromagnetic fields can change the expressions of BCL2, miR-15-b and miR-16.",
  "effect": "mixed",
  "evidence": "low",
  "extraction": {
    "studyType": "in_vitro",
    "studyTypeLabel": "In vitro study",
    "effectDirection": "mixed",
    "evidenceLabel": "Low",
    "population": "Human gastric adenocarcinoma cancer cell line (AGS)",
    "sampleSize": "—",
    "exposure": "ELF · 18 h (continuous or discontinuous 1.5 h on/1.5 h off)",
    "confidencePct": "78",
    "peerReviewed": "yes",
    "mainFindings": "ELF-EMF exposure at 2 mT continuous significantly reduced AGS cell viability. BCL2 expression was significantly decreased after continuous exposure at 0.2 and 2 mT and after discontinuous exposure at 2 mT. miR-15-b and miR-16 expression were significantly increased in both continuous and discontinuous 2 mT conditions.",
    "outcomes": [
      "Cell viability (MTT assay)",
      "BCL2 expression (real-time PCR)",
      "miR-15-b expression (real-time PCR)",
      "miR-16 expression (real-time PCR)"
    ],
    "limitations": [
      "Frequency of the ELF-EMF exposure was not reported in the abstract.",
      "In vitro cancer cell line model",
      "generalizability to humans is not addressed in the abstract.",
      "Sample size/replicates and detailed dosimetry beyond magnetic flux density are not provided in the abstract."
    ],
    "keywords": [
      "ELF-EMF",
      "extremely low frequency",
      "magnetic flux density",
      "0.2 mT",
      "2 mT",
      "AGS",
      "gastric cancer cell line",
      "cell viability",
      "MTT",
      "BCL2",
      "miR-15-b",
      "miR-16",
      "gene expression",
      "real-time PCR"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"in_vitro\",\n  \"exposure\": {\n    \"band\": \"ELF\",\n    \"source\": null,\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": \"18 h (continuous or discontinuous 1.5 h on/1.5 h off)\"\n  },\n  \"population\": \"Human gastric adenocarcinoma cancer cell line (AGS)\",\n  \"sample_size\": null,\n  \"outcomes\": [\n    \"Cell viability (MTT assay)\",\n    \"BCL2 expression (real-time PCR)\",\n    \"miR-15-b expression (real-time PCR)\",\n    \"miR-16 expression (real-time PCR)\"\n  ],\n  \"main_findings\": \"ELF-EMF exposure at 2 mT continuous significantly reduced AGS cell viability. BCL2 expression was significantly decreased after continuous exposure at 0.2 and 2 mT and after discontinuous exposure at 2 mT. miR-15-b and miR-16 expression were significantly increased in both continuous and discontinuous 2 mT conditions.\",\n  \"effect_direction\": \"mixed\",\n  \"limitations\": [\n    \"Frequency of the ELF-EMF exposure was not reported in the abstract.\",\n    \"In vitro cancer cell line model; generalizability to humans is not addressed in the abstract.\",\n    \"Sample size/replicates and detailed dosimetry beyond magnetic flux density are not provided in the abstract.\"\n  ],\n  \"evidence_strength\": \"low\",\n  \"confidence\": 0.78,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"ELF-EMF\",\n    \"extremely low frequency\",\n    \"magnetic flux density\",\n    \"0.2 mT\",\n    \"2 mT\",\n    \"AGS\",\n    \"gastric cancer cell line\",\n    \"cell viability\",\n    \"MTT\",\n    \"BCL2\",\n    \"miR-15-b\",\n    \"miR-16\",\n    \"gene expression\",\n    \"real-time PCR\"\n  ],\n  \"suggested_hubs\": []\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/34791478/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=5667",
  "updated": "2026-02-14 08:50:10"
}